132
Participants
Start Date
November 30, 2015
Primary Completion Date
April 28, 2017
Study Completion Date
April 28, 2017
Hepatitis B vaccine
An eligible participant will receive 3 doses of hepatitis B vaccine ( 20mcg in the deltoid intramuscular). Then their immune response will be assessed. Non responders will receive 3 additional vaccine doses off protocol
Mulago National referral hospital, Kampala
Makerere University
OTHER
Uganda Cancer Institute
OTHER
Fred Hutchinson Cancer Center
OTHER